Table 1.
Baseline characteristics of the control and Stroke cohorts.
| Control cohort (n = 18) | Stroke cohort (n = 18) | P-value | |
|---|---|---|---|
| Age | 64 ± 7.7 | 54 ± 9.6 | 0.002* |
| Sex (male) | 50 (9) | 72.2 (13) | 0.171 |
| RISK FACTORS | |||
| Alcohol | 50 (9) | 16.7 (3) | 0.034* |
| Tobacco | 16.7 (3) | 33.3 (6) | 0.443 |
| Hypertension | 83.3 (15) | 66.7 (12) | 0.443 |
| Dyslipidemia | 66.7 (12) | 44.4 (8) | 0.18 |
| Diabetes mellitus | 22.2 (4) | 16.7 (3) | 1 |
| Atrial fibrillation | 0 (0) | 11.1 (2) | 0.486 |
| Obesity | 66.7 (12) | 38.9 (7) | 0.095 |
| Body mass index (kg/m2) | 26 ± 3.3 | 23.2 ± 3.5 | 0.019* |
| COMORBIDITIES | |||
| Osteoarticular disorders | 22.2 (4) | 11.1 (2) | 0.658 |
| Ischemic cardiopathy | 0 (0) | 5.6 (1) | 1 |
| Psychiatric disorders | 22.2 (4) | 22.2 (4) | 1 |
| PREVIOUS EXERCISE | |||
| Physical activity | 77.8 (14) | 47.1 (8) | 0.06 |
| Physical activity (h) | 7 (5–10) | 0 (0–7) | 0.116 |
| PREVIOUS MEDICATION | |||
| Anti-platelets | 27.8 (5) | 16.7 (3) | 0.674 |
| Anti-coagulants | 0 (0) | 5.6 (1) | 1 |
| Statins | 38.9 (7) | 27.8 (5) | 1 |
| Anti-hypertensives | 77.8 (14) | 44.4 (8) | 0.040* |
| Anti-diabetic | 16.7 (3) | 11.1 (2) | 0.639 |
Variables are expressed as percentage, mean ± SD, median (IQR), and the number of cases as (n); h, hours.
*
p-value < 0.05.